These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 11598252)
21. Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules. Lupescu IG; Capsa RA; Gheorghe L; Herlea V; Georgescu SA J Gastrointestin Liver Dis; 2008 Sep; 17(3):341-6. PubMed ID: 18836633 [TBL] [Abstract][Full Text] [Related]
22. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
23. [Comparative evaluation of echography, computerized tomography and magnetic resonance imaging in the diagnosis of hepatocellular carcinoma in cirrhotic patients]. Dalla Palma L; Pozzi-Mucelli RS; Bazzocchi M; Pozzi-Mucelli R; Ferrara P Radiol Med; 1991; 81(1-2):8-15. PubMed ID: 1848720 [TBL] [Abstract][Full Text] [Related]
24. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119 [TBL] [Abstract][Full Text] [Related]
25. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154 [TBL] [Abstract][Full Text] [Related]
26. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Park MJ; Kim YK; Lee MH; Lee JH Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300 [TBL] [Abstract][Full Text] [Related]
27. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation. van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110 [TBL] [Abstract][Full Text] [Related]
28. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994 [TBL] [Abstract][Full Text] [Related]
29. Imaging of hepatocellular carcinoma and early diagnosis. Limaye AR; Cabrera R Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899 [TBL] [Abstract][Full Text] [Related]
30. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319 [TBL] [Abstract][Full Text] [Related]
31. Guidelines for imaging focal lesions in liver cirrhosis. Lencioni R; Crocetti L; Della Pina MC; Cioni D Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):697-703. PubMed ID: 19072346 [TBL] [Abstract][Full Text] [Related]
32. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR. Bartolozzi C; Battaglia V; Bozzi E Abdom Imaging; 2011 Jun; 36(3):290-9. PubMed ID: 21267561 [TBL] [Abstract][Full Text] [Related]
33. Hemangioma in the cirrhotic liver: diagnosis and natural history. Brancatelli G; Federle MP; Blachar A; Grazioli L Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536 [TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Marin D; Di Martino M; Guerrisi A; De Filippis G; Rossi M; Ginanni Corradini S; Masciangelo R; Catalano C; Passariello R Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848 [TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma: development and early detection. Robinson P Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S128-31. PubMed ID: 18852086 [TBL] [Abstract][Full Text] [Related]
36. CT and MRI of hepatocellular carcinoma: an update. Ayyappan AP; Jhaveri KS Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916 [TBL] [Abstract][Full Text] [Related]
37. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. Oi H; Murakami T; Kim T; Matsushita M; Kishimoto H; Nakamura H AJR Am J Roentgenol; 1996 Feb; 166(2):369-74. PubMed ID: 8553950 [TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Ito K; Mitchell DG; Gabata T; Hann HW; Kim PN; Fujita T; Awaya H; Honjo K; Matsunaga N Radiology; 1999 Jul; 212(1):235-40. PubMed ID: 10405747 [TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Mitchell DG; Rubin R; Siegelman ES; Burk DL; Rifkin MD Radiology; 1991 Jan; 178(1):101-3. PubMed ID: 1845784 [TBL] [Abstract][Full Text] [Related]